Everbridge Acquires Cell Broadcast Technology Leader one2many; Launches Industry’s First Unified Public Warning Platform to Combat COVID-19 Pandemic Globally

▴ Everbridge Acquires Cell Broadcast Technology Leader one2many Launches Industrys First Unified Public Warning Platform to Combat COVID 19 Pandemic Globally
New patent-pending, hybrid Public Warning System (PWS) combines Everbridge’s industry-leading, location-based mobile messaging with best cell broadcast offering to mitigate coronavirus for entire countries while exceeding European Union (EU) regulatory directive for 2022 mandate

Everbridge, Inc., the global leader in critical event management (CEM), today announced that the company has acquired the leading global provider of cell broadcast solutions for safety applications, one2many, in order to provide a mobile-optimized, full-lifecycle solution for meeting and exceeding EU regulatory and other global initiatives for countrywide population alerting.

The combination creates the largest and only public warning system combining cell-broadcast and address-, group-, and location-based, multi-channel technologies. The new hybrid platform enables countries to protect against coronavirus; share updates on viral hotspots and pandemic best practices; coordinate first responders and healthcare resources; establish two-way communications with at-risk populations; and manage disruptions to transportation, education and other critical services. In addition, the platform also provides critical event management capabilities across a broad range of threats including natural disasters, terrorism, cyber, and other security events.

Tags : #Everbridge #Cellbroadcasttech #One2many #Unifiedpublicwarning

About the Author


Team Medicircle

Related Stories

05 Mar

India’s Clinical Trials Market: Can We Leap from Underdog to Global Leader?

The stakes are high, the challenges are many, and the rewards could be transformative not just for India, but for global healthcare as well.

View
14 Sep

Seeking Justice: The Tragic Case of Jaahnavi Kandula and the inhumanity of US police

Jaahnavi's life ended tragically in a police car collision during her Master's pursuit. A detective's callous 'jokes' about her death emphasize the need for empathy and accountability in law enforcement.

View
31 Jul

Revolutionizing Medicine: AI and Brain Implants Restore Sensation to Paralyzed Man

The groundbreaking application of AI and brain implants offers hope to many paralyzed individuals, paving the way for potential advancements in medical science and improving the quality of life for those living with severe physical disabilities.

View
11 Aug

Now that Eyestem is here, Can India now be care free about Dry AMD ?

Dry AMD is the largest cause of incurable blindness in people above 60 and affects roughly 170 million people worldwide.The investment will allow Eyestem to progress treatment for Dry Age-related Macular Degeneration into clinical trials.

View
08 Aug

Eyestem raises $6.4M in Series A round

The investment will allow Eyestem to progress a treatment for Dry Age-related Macular Degeneration into clinical trials.

View
22 Jun

Signs and Symptoms of Alzheimer’s Disease

Alzheimer's disease is a disease that makes no distinctions and takes no sides. It is equally drawn to the wealthy and the impoverished, the famous and the ordinary.

View
23 Aug

Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106

Latest Pharma Update

View
16 Jul

Idifarma launches accelerated pathway for complex drugs

The new service also aims to maximize yield and minimize waste of API

View
20 Mar

Fujitsu Embarks on Joint Research with National Cancer Center Japan

The joint research is aimed to create new services for drug development and clinical trials

View
24 Dec

Serum Institute Of India And Dynavax Announce First Participants Dosed In The Phase 1/2 Clinical Trial For A COVID-19 Vaccine

Serum Institute Of India And Dynavax, today jointly announced that the first participants have been dosed in the Phase 1 part of the Phase 1/2 clinical trial evaluating SIIPL's vaccine candidate adjuvanted with CpG 1018 to prevent COVID-19.

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025